Clinical Trial Update: Quality of Life 1y and 2 y After VV-ECMO for COVID-19

View source ↗

Summary

This trial update reports quality of life at 1 and 2 years after venovenous ECMO (VV-ECMO) in patients with COVID-19–associated acute respiratory distress syndr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Covid-19-associated Acute Respiratory Distress Syndrome

Snippet

Sponsor: University Hospital, Ghent | Conditions: COVID-19 Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation Complication | Status: COMPLETED